Sealive
Sealive is a Japan-based hardware and firmware engineering firm that develops nucleic-acid-degrading gas-phase sterilization systems (steriXcure, steriXmini, Biovector®) and space-grade electronic design services for JAXA satellite missions, serving pharmaceutical, laboratory and aerospace customers from Niihama, Ehime.
- Company typePrivate
- Founded1995
- HeadquartersNiihama, Japan
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sealive does
Sealive, Inc. (株式会社シーライブ), founded in February 1995 in Niihama, Ehime Prefecture, Japan, was a privately held hardware and firmware engineering firm that operated two distinct business divisions from a single headquarters. The System Engineering Business delivered consignment-based design of high-reliability electronics for space and industrial customers, including onboard circuit design, FPGA SpaceWire logic (compliant with ECSS-E-ST-50-12C), DC-DC/DC-AC converters, and a proprietary MCP high-voltage 4-output power supply (5 kV DC, 200 kHz switching) used in JAXA/ISAS observation satellites such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H. Customers on this side included Sumitomo Heavy Industries, Symax, SEIKEN and PHC Corporation. The Life Science Business was built around Biovector®, a proprietary complex gas that the company describes as the only technology in the world that decomposes nucleic-acid (DNA/RNA) structures in the gas phase. Biovector® underpins the steriXcure GE100S Decontamination Gas Generator and the newly introduced compact steriXmini system, plus the setriX nucleic-acid decontamination service line, sold to pharmaceutical, laboratory, animal-research and regenerative-medicine customers with a Sterility Assurance Level of Log10⁻⁶ and 99.994% / LRV4.20 reduction of SARS-CoV-2.
The company monetized through a mix of one-time hardware sales, project-based decontamination installation services, and contract system-engineering engagements; pricing is quote-based with no public list, and customers are routed through bilingual Japanese/English inquiry forms on the corporate website. Go-to-market relied on direct enterprise sales supported by a heavy trade-show cadence (co-exhibiting with parent Mito Kogyo at Regenerative Medicine EXPO, PharmaLab EXPO, JALAS, JAET and Medical Creation Fukushima), Nature Index earned media, downloadable technical PDFs, and standard digital marketing infrastructure (Google Analytics, Mailchimp/AWeber/GetResponse). The technology base has been validated externally via AMED funding (2021) for novel-coronavirus countermeasure R&D, ISO 9001-based QMS, Ehime Sugo-waza and Niihama Manufacturing Brand certifications, and the 2022 Shikoku Industrial Technology Award for steriXcure.
As of October 1, 2025, Sealive was merged into Mito Kogyo Corporation (水戸工業株式会社) and continues to operate as the newly established Ehime Electrical and Electronic Design Center of Mito Kogyo, with founder-CEO Yasushi Suzuki serving as Center Director and Ryuzo Narita as Representative Director of the surviving parent.
Sealive firmographics
Firmographics- Name
- Sealive
- Legal name
- Sealive, Inc. (株式会社シーライブ)
- Website
- https://sealive.co.jp
- Company type
- Private
- Founded year
- 1995
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Sealive is a Japan-based hardware and firmware engineering firm that develops nucleic-acid-degrading gas-phase sterilization systems (steriXcure, steriXmini, Biovector®) and space-grade electronic design services for JAXA satellite missions, serving pharmaceutical, laboratory and aerospace customers from Niihama, Ehime.
- Ownership category
- akta.pro rank
Sealive industry classification
Industry- Product category
- Gas-Phase Sterilization and Decontamination Equipment
- NAICS
- Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413), Aerospace Product and Parts Manufacturing (3364), Computer Systems Design and Related Services (54151)
- SIC
- Laboratory Analytical Instruments (3826), Printed Circuit Boards (3672)
- akta.pro primary industry
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
- akta.pro secondary industries
- mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF), Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream) (HLAAACAN), Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC)
Keywords
Where Sealive is headquartered
LocationHeadquarters
- HQ city
- Niihama
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Sealive business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- steriXcure / steriXmini equipment sales: One-time hardware sales of gas-phase decontamination systems (GE100S, steriXmini) to laboratory, pharmaceutical, animal-facility and medical-device customers.
- Decontamination installation / nucleic-acid decontamination services: Professional services offering site decontamination of nucleic-acid contaminated areas, preventive decontamination, and consultation services using the setriX series, charged per project/contract.
- System Engineering contract design & development: Consignment/contract-based revenue from system construction, hardware, firmware, and software design — including space-grade onboard electronics — delivered to enterprise customers.
- HACCP management system marketing support (AWS-based): Marketing support services for HACCP management systems based on AWS for life-science / food-safety customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for steriXcure / steriXmini systems and decontamination services |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Sealive product offering
Product offeringCore offering
Sealive designs, manufactures and sells gas-phase nucleic-acid decontamination systems (steriXcure GE100S and steriXmini) powered by its proprietary Biovector® complex gas, which decomposes DNA and RNA structures to deliver SAL = Log10⁻⁶ sterility and 99.994% / LRV4.20 reduction of SARS-CoV-2 in laboratory, pharmaceutical, clean-room and animal-facility environments. Alongside this Life Science line, the company delivers contracted space-grade hardware, firmware and PCB design services — including DC-DC converters, SpaceWire FPGA logic and 5 kV DC MCP high-voltage power supplies — for JAXA/ISAS scientific-satellite programs such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H/NeXT.
Product overview
Sealive (株式会社シーライブ), now operating as the Ehime Electrical and Electronic Design Center of Mito Kogyo Co., Ltd. (水戸工業株式会社) following an October 1, 2025 corporate merger, runs two distinct business divisions from its base in Niihama, Ehime Prefecture. The Life Science Business is built around the proprietary Biovector® nucleic-acid-degrading gas-phase technology and is commercialized primarily through the flagship steriXcure GE100S Decontamination Gas Generator, the newly introduced next-generation steriXmini DNA-free Decontamination System, and the setriX Series Nucleic Acid Decontamination Service — together forming an integrated hardware-plus-service offering for sterilization, DNA-free environment regeneration, viral clearance, and oxidative deodorization. The System Engineering Business complements this by providing space-grade hardware design, embedded software/firmware development, and printed circuit board design services, with a proven track record on JAXA/ISAS observation satellites. The two divisions are housed within the same electronics-engineering organization and share underlying competencies in electronic circuit design and embedded control, while targeting fundamentally different end markets (life-science laboratories and cleanrooms vs. space and industrial electronics).
Differentiator
Problem solved
Functional benefit
Brands
- steriXcure: Trademarked nucleic acid degradable gas-phase sterilization/decontamination product line for pathogens and viruses; the company's flagship life science brand encompassing the GE100S decontamination gas generator and the steriXmini compact DNA-free decontamination system.
Products and services
- steriXcure GE100S Decontamination Gas Generator
Quantifiable outcome
- 99.994% virus reduction / LRV4.20 against SARS-CoV-2 (TCID50)
- +4 more outcomes
Companies that use Sealive
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
Sealive technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Sealive partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship / core and strategic tier.
- Mito Kogyo Co., Ltd. (水戸工業株式会社)flagship / coreAs of October 1, 2025, Mito Kogyo Co., Ltd. merged with Sealive, Inc., and Sealive was newly established as the "Ehime Electrical and Electronic Design Center" of Mito Kogyo. All business operations and responsibilities of the former Sealive were fully succeeded by Mito Kogyo. Mito Kogyo Representative Director: Ryuzo Narita; Ehime Center Director: Yasushi Suzuki.
- Nature Research Custom Media (Nature Index)strategic tierFeatured in Nature Index — Infectious disease special, October 28, 2021, with the article "The next milestone in sterilization" highlighting steriXcure / Biovector. Provides international scientific credibility and earned-media visibility for the technology.
- Mito Kogyo Co., Ltd. (booth partnership at trade shows)flagship / coreSealive exhibits inside the Mito Kogyo booth at major Japanese trade shows (PharmaLab EXPO Osaka booth 11-33; Regenerative Medicine EXPO Tokyo West Hall W7-26; JALAS booth F-9; JAET booth D-12; Medical Creation Fukushima booth A-1 within MECT booth), leveraging Mito Kogyo's larger commercial footprint.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Sealive competitors and assessment
Company assessmentBroad incumbents
- Getinge: Broad sterilization and infection-control equipment incumbent with a global service network serving hospitals, pharmaceutical manufacturers, and research labs. Overlaps with Sealive's life-science sterilization customer base as part of a much wider portfolio.
- NEC (NEC Space Technologies): Long-standing Japanese supplier of space-grade electronic systems for JAXA and commercial satellite programs. Comparable in the System Engineering Business dimension as a large incumbent in satellite onboard electronics.
- Advanced Sterilization Products (Johnson & Johnson MedTech): Sterilization and disinfection solutions provider within J&J MedTech, serving hospitals and life-science customers. Broad incumbent overlapping with Sealive's decontamination end markets.
- Mitsubishi Electric: Major Japanese aerospace electronics manufacturer supplying satellite onboard systems. Comparable in the System Engineering Business dimension as a much larger incumbent in space-grade electronics design and manufacture.
Emerging players
- Noxilizer: Nitrogen dioxide-based sterilization technology targeted at pharma, biotech, and medical-device customers. Comparable niche modality player focused on alternative gas-phase sterilization approaches for the same regulated buyers.
Direct peers
- Bioquell (Ecolab): Hydrogen peroxide vapor decontamination systems for life-science and pharmaceutical cleanrooms, now part of Ecolab. Closely comparable technology approach and customer base to Sealive's gas-phase nucleic-acid decontamination.
- TOMI Environmental Solutions: Provider of SteraMist ionized hydrogen peroxide decontamination technology for life sciences, healthcare, and public-sector buyers. Comparable niche-scale player offering a differentiated gas-phase decontamination modality.
- STERIS: Global leader in sterilization and decontamination equipment for pharmaceutical, biotech, and medical-device customers. Directly comparable as a vendor of gas-/vapor-phase decontamination systems targeting the same regulated end markets Sealive serves with steriXcure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Sealive compliance and trust
Trust signalCompliance5 records
Sealive financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sealive leadership team
Management profileNumber of profiles
Profiles2 records
Sealive funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sealive M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sealive
What does Sealive do?
Sealive designs, manufactures and sells gas-phase nucleic-acid decontamination systems (steriXcure GE100S and steriXmini) powered by its proprietary Biovector® complex gas, which decomposes DNA and RNA structures to deliver SAL = Log10⁻⁶ sterility and 99.994% / LRV4.20 reduction of SARS-CoV-2 in laboratory, pharmaceutical, clean-room and animal-facility environments. Alongside this Life Science line, the company delivers contracted space-grade hardware, firmware and PCB design services — including DC-DC converters, SpaceWire FPGA logic and 5 kV DC MCP high-voltage power supplies — for JAXA/ISAS scientific-satellite programs such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H/NeXT.
Is Sealive a public or private company?
Sealive is a private company. It is classified as corporate owned and is currently acquired.
When was Sealive founded?
Sealive was founded in 1995. It employs 11 to 50 people.
Where is Sealive based?
Sealive is headquartered in Niihama, Japan, in the Asia region.
How does Sealive make money?
Four revenue lines are on record. steriXcure / steriXmini equipment sales are the primary driver. The others are decontamination installation / nucleic-acid decontamination services, system Engineering contract design & development and HACCP management system marketing support (AWS-based).
Who are Sealive's main competitors?
Broad incumbents on record are Getinge, NEC (NEC Space Technologies), Advanced Sterilization Products (Johnson & Johnson MedTech) and Mitsubishi Electric. Noxilizer is listed as an emerging player. Direct peers are Bioquell (Ecolab), TOMI Environmental Solutions and STERIS.
Does Sealive have an API?
No public API is recorded for Sealive.
What industry is Sealive in?
Sealive's product category is Gas-Phase Sterilization and Decontamination Equipment. Its primary akta.pro industry code is HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA), with a secondary code of HLAGABAF, mRNA/LNP & Nucleic Acid Therapeutics CDMO. Its NAICS code is 333413 and its SIC code is 3826.